1443 related articles for article (PubMed ID: 9295029)
21. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
[TBL] [Abstract][Full Text] [Related]
22. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
23. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.
Pajot A; Schnuriger A; Moris A; Rodallec A; Ojcius DM; Autran B; Lemonnier FA; Lone YC
Eur J Immunol; 2007 Sep; 37(9):2635-44. PubMed ID: 17668896
[TBL] [Abstract][Full Text] [Related]
24. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
25. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
26. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
27. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
[TBL] [Abstract][Full Text] [Related]
28. Cell surface expression of class II MHC proteins bound by a single peptide.
Ignatowicz L; Winslow G; Bill J; Kappler J; Marrack P
J Immunol; 1995 Apr; 154(8):3852-62. PubMed ID: 7706725
[TBL] [Abstract][Full Text] [Related]
29. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
Demotz S
Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
[TBL] [Abstract][Full Text] [Related]
30. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.
Panina-Bordignon P; Tan A; Termijtelen A; Demotz S; Corradin G; Lanzavecchia A
Eur J Immunol; 1989 Dec; 19(12):2237-42. PubMed ID: 2481588
[TBL] [Abstract][Full Text] [Related]
31. Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules. Influence of the beta 2-domain correlates with CD4 dependence.
Lombardi G; Barber L; Aichinger G; Heaton T; Sidhu S; Batchelor JR; Lechler RI
J Immunol; 1991 Sep; 147(6):2034-40. PubMed ID: 1716292
[TBL] [Abstract][Full Text] [Related]
32. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
[TBL] [Abstract][Full Text] [Related]
33. Soluble mouse major histocompatibility complex class II molecules produced in Drosophila cells.
Wallny HJ; Sollami G; Karjalainen K
Eur J Immunol; 1995 May; 25(5):1262-6. PubMed ID: 7774629
[TBL] [Abstract][Full Text] [Related]
34. Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
Kuijpers KC; Treep-Van Leeuwen P; Miedema F; Lucas CJ
Eur J Immunol; 1991 Jun; 21(6):1453-60. PubMed ID: 1710566
[TBL] [Abstract][Full Text] [Related]
35. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
36. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule.
Fernández MM; Guan R; Swaminathan CP; Malchiodi EL; Mariuzza RA
J Biol Chem; 2006 Sep; 281(35):25356-64. PubMed ID: 16829512
[TBL] [Abstract][Full Text] [Related]
38. DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein.
Van Schooten WC; Elferink DG; Van Embden J; Anderson DC; De Vries RR
Eur J Immunol; 1989 Nov; 19(11):2075-9. PubMed ID: 2480902
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
[TBL] [Abstract][Full Text] [Related]
40. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
